Atara Biotherapeutics, Inc.

ALLELE

Developing pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting; conducting clinical trials of pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting; conducting clinical research of the effectiveness of pharmaceutical and therapeutic preparations, namely, by conducting clinical trial on patients with EBV-Associated Post Transplant Lymphoproliferative Disease (EBV-PTLD);

ATARA

House mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis;

ATARA

house mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis;

ATARA BIO

The mark consists of the phrase ATARA BIO in black lettering with an abstract design of a crown in yellow and green stacked on top of the phrase.;House mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis;The color(s) yellow, green and black is/are claimed as a feature of the mark.;